GTC-Solid Tumor Profile
GTR Test Accession: Help GTR000591799.2
CAP
Last updated in GTR: 2020-09-02
Last annual review date for the lab: 2023-07-11 LinkOut
At a Glance
Mutation Confirmation; Therapeutic management; Prognostic; ...
Solid tumor
ABCB7 (Xq13.3), ABL1 (9q34.12), ABL2 (1q25.2), ABRAXAS1 (4q21.23), ACD (16q22.1), ...
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Patients with various solid tumors including cancers of the lung, …
Not provided
Not provided
Ordering Information
Offered by: Help
Genomic Testing Cooperative, LCA
View lab's website
View lab's test page
Test short name: Help
Solid Tumor Profile
Manufacturer's name: Help
Laboratory Developed Test
Specimen Source: Help
Who can order: Help
  • Licensed Physician
  • Physician Assistant
  • Nurse Practitioner
Test Order Code: Help
CPT codes: Help
**AMA CPT codes notice
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Complete Requisition, making sure all sections are completed in their entirety including Client information, Patient Information, Specimen Information and Test Selection. Insure the specimen is labeled with patient name and number. A minimum of two patient identifiers is REQUIRED for each specimen. Diagnosis/Patient History is extremely important in rendering the …
View more
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
    OrderCode: GTC-Hematology Profile, GTC-Hematology Profile Plus Fusion/Expression, GTC-Solid Tumor Profile, GTC-Solid Tumor Fusion/Expression Profile,GTC-Solid Tumor Profile Plus Expression
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
No
Pre-test genetic counseling required: Help
No
Post-test genetic counseling required: Help
No
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 434
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Mutation Confirmation; Therapeutic management; Prognostic; Monitoring; Diagnosis
Target population: Help
Patients with various solid tumors including cancers of the lung, pancreas, brain, colon, breast, ovary, endometrium, thyroid, head and neck, and soft tissue (sarcoma and GIST).
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
The analytic validity was established with unique variants consisting of 1814 SNVs and 67 indels. The Sensitivity/Variant-level PPA (95% CI) was 0.9895 CI:0.983 to 0.993 for SNVs and 1.0 CI:0.983 to 1.0 for indels. The Specificity/ Variant-level NPA (95% CI) was 1.00 CI: 0.996 to 1.00 for SNVs and 1.00 … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: Not Applicable
NYS CLEP Approval: Help
Number:
Status: Pending
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.